282 related articles for article (PubMed ID: 32513307)
1. Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
Isselhard A; Töpper M; Berger-Höger B; Steckelberg A; Fischer H; Vitinius F; Beifus K; Köberlein-Neu J; Wiedemann R; Rhiem K; Schmutzler R; Stock S
Trials; 2020 Jun; 21(1):501. PubMed ID: 32513307
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
4. Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study.
Berger-Höger B; Vitinius F; Fischer H; Beifus K; Köberlein-Neu J; Isselhard A; Töpper M; Wiedemann R; Rhiem K; Schmutzler R; Stock S; Steckelberg A
BMC Nurs; 2022 Feb; 21(1):42. PubMed ID: 35139834
[TBL] [Abstract][Full Text] [Related]
5. Nurse-led coaching of shared decision-making for women with ductal carcinoma in situ in breast care centers: A cluster randomized controlled trial.
Berger-Höger B; Liethmann K; Mühlhauser I; Haastert B; Steckelberg A
Int J Nurs Stud; 2019 May; 93():141-152. PubMed ID: 30925280
[TBL] [Abstract][Full Text] [Related]
6. Informed shared decision-making supported by decision coaches for women with ductal carcinoma in situ: study protocol for a cluster randomized controlled trial.
Berger-Höger B; Liethmann K; Mühlhauser I; Haastert B; Steckelberg A
Trials; 2015 Oct; 16():452. PubMed ID: 26458964
[TBL] [Abstract][Full Text] [Related]
7. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
8. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
Trials; 2016 Jul; 17():368. PubMed ID: 27473440
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S; Redaèlli M; Shukri A; Kentenich H; Simic D; Mildenberger V; Schmutzler R; Rhiem K; Stock S
BMC Med Inform Decis Mak; 2023 Oct; 23(1):223. PubMed ID: 37845719
[TBL] [Abstract][Full Text] [Related]
10. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
11. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
[TBL] [Abstract][Full Text] [Related]
12. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial.
Metcalfe KA; Dennis CL; Poll A; Armel S; Demsky R; Carlsson L; Nanda S; Kiss A; Narod SA
Genet Med; 2017 Mar; 19(3):330-336. PubMed ID: 27584910
[TBL] [Abstract][Full Text] [Related]
13. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
Kautz-Freimuth S; Redaèlli M; Rhiem K; Vodermaier A; Krassuski L; Nicolai K; Schnepper M; Kuboth V; Dick J; Vennedey V; Wiedemann R; Schmutzler R; Stock S
BMC Med Inform Decis Mak; 2021 Jun; 21(1):180. PubMed ID: 34090422
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
[TBL] [Abstract][Full Text] [Related]
15. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
[TBL] [Abstract][Full Text] [Related]
16. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
17. Breast self-examination education for BRCA mutation carriers by clinical nurse specialists.
Visser A; Bos WC; Prins JB; Hoogerbrugge N; van Laarhoven HW
Clin Nurse Spec; 2015; 29(3):E1-7. PubMed ID: 25856039
[TBL] [Abstract][Full Text] [Related]
18. Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.
Rahn AC; Köpke S; Kasper J; Vettorazzi E; Mühlhauser I; Heesen C
Trials; 2015 Mar; 16():106. PubMed ID: 25872529
[TBL] [Abstract][Full Text] [Related]
19. Implementation of shared decision-making in oncology: development and pilot study of a nurse-led decision-coaching programme for women with ductal carcinoma in situ.
Berger-Höger B; Liethmann K; Mühlhauser I; Steckelberg A
BMC Med Inform Decis Mak; 2017 Dec; 17(1):160. PubMed ID: 29212475
[TBL] [Abstract][Full Text] [Related]
20. Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.
Puski A; Hovick S; Senter L; Toland AE
J Genet Couns; 2018 Sep; 27(5):1291-1301. PubMed ID: 29594659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
